Leading Independent Investment Research, Morningstar, Inc.

Morningstar

Leading Independent Investment Research

Morningstar, Inc.

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. We offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors. 

Morningstar provides data on more than 500,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 16 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries, with more than $180 billion in assets under advisement or management as of June 30, 2015. We have operations in 27 countries.

Download the Morningstar Fact Sheet : http://corporate.morningstar.com/US/documents/MarketingFactSheets/AboutMorningstarFactsheet.pdf

Equity Bottom-Up

Infratil sold its 20% stake in Metlifecare for NZD 238 million, booking a tidy profit of around NZD 90 million (NZD 16 cents per share) and collecting dividends along the way. All up, the firm made 15% per year since buying the stake in October 2013, an excellent return. While positive on the outlook for the retirement sector, we're happy to see the firm free up more capital to invest in its core businesses.We adjust our forecasts but maintain our NZD 3.30 per share fair value estimate. At the current stock price of NZD 3.00, Infratil is modestly undervalued. There is no change to the firm's narrow economic moat rating, which is underpinned by investments in good-quality underlying assets.Analysts: Adrian Atkins and Daniel Ragonese

Infratil sold its 20% stake in Metlifecare for NZD 238 million, booking a tidy profit of around NZD 90 million (NZD 16 cents per share) and collecting dividends along the way. All up, the firm made 15% per year since buying the stake in October 2013, an excellent return. While positive on the outlook for the retirement sector, we're happy to see the firm free up more capital to invest in its core businesses.We adjust our forecasts but maintain our NZD 3.30 per share fair value estimate. At the current stock price of NZD 3.00, Infratil is modestly undervalued. There is no change to the firm's narrow economic moat rating, which is underpinned by investments in good-quality underlying assets.Analysts: Adrian Atkins and Daniel Ragonese

Infratil Sells Stake in Metlifecare for Tidy Profit

Infratil Ltd

Infratil Sells Stake in Metlifecare for Tidy Profit